Burjeel Hospitals Launches Trucheck Blood Test For Early Cancer Detection And Prevention

Burjeel Hospitals has introduced Trucheck™ intelli, a non-invasive test for early cancer detection. This advanced diagnostic tool requires only a blood sample and can identify over 70 types of solid tumors. With the global cancer burden increasing, early detection is crucial for improving survival rates. Trucheck aims to play a significant role in this effort by offering a new standard in preventive healthcare.

According to the World Health Organisation (WHO), cancer ranks as the second leading cause of death worldwide. Early diagnosis and advanced care can significantly enhance survival rates. Trucheck is designed to detect circulating tumor cells (CTCs) and molecular signatures that indicate cancer presence. This innovative approach allows for early detection, often before symptoms appear.

Trucheck boasts an accuracy rate exceeding 95% in detecting cancers such as breast, lung, pancreatic, liver, thyroid, and gastrointestinal types. Unlike tests focusing on circulating tumor DNA (ctDNA) methylation patterns, Trucheck uses intact tumor cells as biomarkers. Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute (BCI), explained that CTCs provide more direct signals of malignancy and offer detailed morphological and protein-level information.

The introduction of Trucheck at Burjeel Hospitals marks a significant step forward in preventive cancer care. The test's rapid result turnaround aids clinicians in making timely treatment decisions tailored to individual needs. It does not require fasting or preparation, making it convenient for asymptomatic individuals aged 40 and above.

This testing method serves as a valuable tool for the general population, high-risk individuals with genetic or family histories, and patients under post-treatment surveillance. It delivers highly accurate results with minimal false positives or negatives. Opting for this test annually can help ensure a cancer-free life.

Dr. Humaid emphasised the importance of early diagnosis in cancer care: "In cancer care, early diagnosis is the cornerstone. It makes a huge difference." By introducing Trucheck, Burjeel Hospitals aim to bring precision and accessibility to preventive cancer care, potentially saving lives while reducing the social and economic burden of cancer.

With inputs from WAM